Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion errors: scope of the problem, consequences, and solutions.

K Sazama1

  • 1The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 800, Houston, TX 77030, USA. ksazama@mdanderson.org

Current Hematology Reports
|October 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate adverse reactions to platelet transfusions: whole blood derived versus apheresis platelets.

Mymensingh medical journal : MMJ·2013
Same author

The ethics of blood management.

Vox sanguinis·2007
Same author

Pretransfusion compatibility testing for red blood cell administration.

Current opinion in hematology·2001
Same author

Is undertransfusion occurring?

Transfusion·2001
Same author

Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. College of American Pathologists.

Archives of pathology & laboratory medicine·2000
Same author

The changing relationships in transfusion medicine.

Archives of pathology & laboratory medicine·1999
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

ABO transfusion errors remain a leading cause of noninfectious transfusion deaths in the US. Research focuses on identifying error causes and implementing solutions like improved processes and technology to enhance patient safety.

Area of Science:

  • Transfusion Medicine
  • Patient Safety
  • Healthcare Quality Improvement

Background:

  • ABO transfusion errors have been the primary cause of noninfectious transfusion deaths in the US for over 25 years.
  • The US ABO error rate ranges from 1:12,000 to 1:19,000, with significant fatality rates.
  • International research has intensified over the last 15 years to understand and mitigate these errors.

Purpose of the Study:

  • To analyze the frequency and nature of ABO transfusion errors.
  • To identify effective solutions for reducing transfusion-related errors and deaths.
  • To establish performance standards for transfusion practices.

Main Methods:

  • Review of international research on transfusion errors.
  • Analysis of error rates and fatality data in the US.

Related Experiment Videos

  • Evaluation of proposed solutions including process changes and technological advancements.
  • Main Results:

    • ABO errors are a persistent and significant cause of transfusion-related mortality.
    • International collaboration has increased to address transfusion safety.
    • Multiple strategies are being explored to minimize transfusion errors.

    Conclusions:

    • Reducing ABO transfusion errors requires a multi-faceted approach.
    • Technological improvements and standardized performance benchmarks are crucial.
    • Continued research and professional society involvement are essential for enhancing transfusion safety.